I help health systems, digital health companies, and pharmaceutical teams turn obesity science into practical care: clinical pathways, provider education, and outcomes they can measure.
My work focuses on three practical questions: how care is delivered, how patients are supported over time, and how outcomes are measured.
PRIORITY 01
Prescribing without infrastructure
Define the care that surrounds prescribing: titration, side-effect triage, nutrition and resistance-training support, and a clear response to plateau. Give each task an owner and an escalation pathway.
PRIORITY 02
The discontinuation curve
Weight regain after stopping treatment is a meaningful risk. In the STEP 1 extension, participants regained about two-thirds of their prior loss during the year after semaglutide and lifestyle support stopped. Individual trajectories vary. Read the study
PRIORITY 03
Measuring the wrong thing
Track weight change, treatment persistence, and metabolic outcomes alongside visits and prescriptions. Report who was included, who left care, and whose follow-up data are missing.
My focus: care teams with a clear plan, and outcomes with a clear denominator.
The Approach
Built by someone who ran the thing you're building.
As co-founder and former chief medical officer of Accomplish Health, I worked across clinical protocols, staffing, payer relationships, and outcomes reporting. That operating experience informs each engagement.
Diagnose
A structured review of your protocols, staffing model, patient journey, persistence data, and outcome definitions. You get a written findings document, not a slide deck of generalities.
Design
Clinical pathways, titration and tolerability protocols, escalation and de-escalation criteria, multidisciplinary roles, and the measurement spine that proves it's working.
Deploy
Provider training, decision support, and the operational detail that determines whether a protocol gets followed or quietly ignored in week three.
Defend
Outcomes reporting your CFO and your payer partners will actually accept — and the ongoing review cadence that keeps performance from drifting.
Published Research
The results, with context
Accomplish Health weight-outcome research coauthored by Dr. Albert and presented at ObesityWeek and ASMBS.
ASMBS 2025 · Medical care
Virtual medical management
19.1% median weight loss at 12 months · n=71
Adults completing 12 months with verified connected-scale weights. Treatment included medication, behavioral care, and dietitian support.
Patients with suboptimal outcomes or weight recurrence after surgery received medical therapy. Weight change was measured during virtual care, not from the original surgery.
The between-group differences in the 2025 analysis were not statistically significant. These groups are not independent replications of the same treatment.
Compare the reported cohorts · 2023–2025
Median total body weight loss among reported completer groups
The two 2023 cohorts were mutually exclusive within that report. The 2024 general cohort required baseline and 12-month connected-scale weights. The diabetes analysis required weight and HbA1c at months 1 and 12; all eight participants were taking tirzepatide at month 12.
How to interpret these results: Retrospective, uncontrolled conference-abstract analyses of patients with follow-up, not estimates for everyone entering care. Missing outcomes were not imputed; these are not intention-to-treat analyses. Participant overlap between reports is unresolved, so sample sizes are not summed and medians are not pooled. The 18.4–24.1% range describes reported 12-month group medians, not individual outcomes or a treatment-effect estimate.
Disclosure: Dr. Albert co-founded Accomplish Health and served as its chief medical officer.
Consulting
Six ways I work with organizations
Select any area to see what's included and who it's for.
01Obesity Program Design
End-to-end architecture for health systems, medical groups, and digital health companies launching or scaling obesity medicine — from clinical protocols and staffing models to intake criteria, escalation pathways, and the outcomes spine that proves the program works.
Practical frameworks for GLP-1, dual, and triple agonist prescribing at scale. This is the operational layer most programs skip: what to do at week 6 when nausea stalls titration, how to handle plateau, when to switch, and how to keep patients on therapy long enough to benefit.
Titration and tolerability protocols
Side-effect triage and de-prescribing criteria
Persistence and adherence strategy
Muscle preservation and nutrition guardrails
03Clinical Education & CME
Grand rounds, CME programs, provider workshops, and decision-support tools for clinical teams navigating a field that changes faster than the guidelines do. Built for clinicians who want mechanism and evidence, not a pharma slide deck.
Grand rounds and department lectures
Accredited CME program development
Hands-on provider workshops
Point-of-care decision support tools
04Strategic Medical Advisory
Clinical perspective for health tech, pharmaceutical, and digital health organizations — product and protocol review, clinical strategy, KOL engagement, and honest assessment of whether a claim will survive scrutiny from practicing physicians.
Product and clinical model review
Medical advisory board participation
Evidence review and claims assessment
Market and positioning input grounded in clinical reality
05Quality & Outcomes Review
A data-driven audit of an existing program with a prioritized set of changes. Where is attrition concentrated? Which cohorts underperform and why? What would move average percent weight change by two points next quarter?
Cohort and attrition analysis
Benchmarking against published real-world data
Prioritized remediation roadmap
Payer-ready outcomes narrative
06Medical Writing & Editorial
White papers, policy briefs, clinical education materials, and editorial content for clinical and executive audiences. Evidence-first, appropriately hedged, and written to be read by people who will check the citations.
White papers and policy briefs
Clinical education and patient-facing materials
Executive-audience explainers
Editorial review for clinical accuracy
Engagements
Four ways to start
Most relationships begin small and expand. Scope and investment are confirmed in writing before any work begins — no open-ended hourly billing.
Advisory Session
Half-day · single topic
A focused working session on one decision: a protocol you're drafting, a model you're evaluating, a build-versus-buy question. Comes with a written summary and recommendations.
Scoped per sessionFastest way to test fit
Most common
Program Design Sprint
6–12 weeks · fixed fee
Diagnose, design, and hand off. Protocols, staffing model, patient journey, and outcomes framework — documented, defensible, and ready for your team to run.
Fixed project feeDeliverables agreed up front
Ongoing Clinical Advisory
Monthly retainer
Standing clinical counsel: a set block of time each month for protocol questions, outcomes review, product decisions, and advisory board participation.
Monthly retainerMinimum three-month term
Speaking & Grand Rounds
Single date · virtual or onsite
Keynotes, grand rounds, CME sessions, and provider workshops. Customized to your audience — clinicians, executives, or both.
Per engagementVirtual and onsite available
About
Clinical rigor for a complex disease
I went into obesity medicine because it was the part of internal medicine where the gap between what we knew and what we did was widest. Patients were being told to try harder for a disease with a well-described neuroendocrine basis. The tools that finally worked arrived faster than the systems needed to deliver them.
I'm a board-certified obesity medicine physician, Chief Medical Officer of Vineyard, and faculty in the Department of Internal Medicine at the University of Oklahoma Health Sciences Center. Before that, I co-founded Accomplish Health, where we built a fully virtual, insurance-covered obesity practice combining medical management, FDA-approved pharmacotherapy, personalized nutrition coaching, and connected technology. See the published outcomes and study limitations.
I trained in internal medicine at Cedars-Sinai, completed the Kennamer Fellowship, and founded its Weight Management Clinic. I previously served as a Clinical Assistant Professor of Medicine at UCLA.
My consulting work brings that experience to the decisions your team faces: what to standardize, when to escalate care, and how to evaluate whether a change is helping.
Alongside the consulting work, I write Substance Over Noise and reach more than 300,000 people across social platforms with evidence-based obesity education. The audience keeps me honest: it's mostly clinicians, and they check the citations.
Clinical commentary on obesity pharmacotherapy, AI in medicine, and the systems that deliver — or fail to deliver — care. Written for physicians, operators, and leaders who'd rather have the study than the headline.
GLP-1 and incretin therapy, with the caveats intact
Trial readouts translated for clinical decisions
Health systems and digital health analysis
8,500+ subscribers · unsubscribe anytime
Speaking & Education
Translating evidence into clinical practice
Grand rounds, CME programs, conference keynotes, and provider workshops — built for audiences that want mechanism, data, and honest uncertainty rather than a highlight reel.
Watch a lecture
Pharmacotherapy for Obesity: An Update
A recorded presentation by Dr. Albert. View the original recording and its publication date on YouTube.
Health systems and medical groups building or scaling obesity medicine; digital health and telehealth companies delivering incretin therapy; employers and health plans evaluating coverage strategy; and pharmaceutical, device, and investment organizations that need clinical perspective grounded in how care is actually delivered.
What does a first engagement look like?
A 30-minute fit call at no cost — you can book it directly from this page — to understand the problem and determine whether I'm the right person for it. If there's a fit, the usual next step is a scoped diagnostic of the current program — protocols, staffing, persistence, and outcome definitions — producing a written findings document and a prioritized roadmap. Many relationships stop there; others expand into design or ongoing advisory.
How is pricing structured?
Fixed fees for defined projects, monthly retainers for ongoing advisory, and per-engagement rates for speaking. Scope and investment are agreed in writing before work begins. I don't bill open-ended hourly, because it rewards the wrong thing.
Do you see individual patients through this site?
No. Michael Albert MD LLC provides consulting and advisory services to organizations. Nothing on this site constitutes medical advice or establishes a physician-patient relationship. If you're looking for care for yourself, please speak with a licensed clinician in your state.
What makes your perspective different from a traditional consultant?
My perspective comes from building and operating a virtual obesity practice: developing protocols, training clinicians, working with payers, and reviewing outcomes. I bring those responsibilities into the recommendations and deliverables for your team.
Can you speak at our conference or grand rounds?
Yes — keynotes, grand rounds, CME programs, and provider workshops, virtual or onsite. Sessions are customized to the audience; book a fit call or send the date, format, and audience profile through the form and I'll confirm availability.
How quickly will I hear back?
Typically within two business days. If your timeline is tighter than that, say so in the message and I'll prioritize accordingly.
Do you have availability right now?
I take a limited number of concurrent engagements so that each gets real attention. Current capacity is noted at the top of this page; if the calendar is full, I'll say so on the fit call rather than stringing out a scoping process.
Contact
Let's find out if this is a fit
Whether you're standing up an obesity program, evaluating a clinical model, or looking for a speaker who'll tell your audience what the data actually shows — grab a time on my calendar, or send the details and I'll tell you honestly whether I can help.
Book a 30-minute fit callPick any open slot. No cost, no pitch — just a conversation about whether I can help.
